Marco Mohwinckel is partner at Janssen Healthcare Innovation (JHI) in Europe, Middle East and Africa (EMEA). Prior to taking on this role, Marco was heading up the Neuroscience Business Unit and was a member of the United Kingdom Management Committee of Janssen Pharmaceutical Companies of Johnson & Johnson in the U.K. In this capacity, he was responsible for driving sales and marketing of the leading Janssen brands in the U.K. and has launched first-in-kind partnership working models with the National Health Service.
Before joining Janssen as Strategic Marketing Director in the Anti-Infectives franchise in EMEA in 2007, Marco was principal at the global strategy consulting firm Monitor Group, where he advised numerous clients in the life science sector across three continents on a wide range of strategic and operational issues. He joined JHI because he believes the group will “contribute to the transformation of Janssen and Johnson & Johnson and play an active role in shaping the future of healthcare,” and looks forward to meeting the challenges of “rethinking, re-organizing and optimizing healthcare delivery.” Marco holds a Bachelor’s degree in Economics and Business Administration from Bocconi University in Milan, Italy.